Engineered cardiac tissues (ECTs) derived from human induced pluripotent stem cells
(hiPSCs) are viable alternatives for cardiac repair, patient‐specific disease modeling, and …

Cardiomyocyte differentiation and proliferation are essential processes for the regeneration
of an injured heart. In recent years, there have been several reports highlighting the …

Cardiovascular diseases are the leading cause of death worldwide. Several strategies–
small molecules, gene therapy, surgeries, cardiac rehabilitation–have been developed to …

Background Acute compartment syndrome (ACS) is one of the most common complications
of musculoskeletal injury, leading to the necrosis and demise of skeletal muscle cells. Our …

Retinal degeneration (RD), a group of diseases leading to irreversible vision loss, is
characterised by retinal pigment epithelium (RPE) or retinal neuron damage and loss. With …

Background Stem cell-derived extracellular vesicles (EVs) are an emerging class of
therapeutics with excellent biocompatibility, bioactivity and pro-regenerative capacity. One of …

Extracellular vesicles (EVs) derived from mesenchymal stromal cells (MSCs) act as
signaling mediators of cellular responses. However, despite representing a promising …

Extracellular vesicles (EVs) have emerged as important mediators of intercellular
communication in the heart under homeostatic and pathological conditions, such as …

Extracellular vesicle (EV)-based approaches for promoting angiogenesis have shown
promising results. Yet, further development is needed in vehicles that prolong EV exposure …

Extracellular vesicles (EVs) secreted by human‐induced pluripotent stem cells (hiPSCs)
have great potential as cell‐free therapies in various diseases, including prevention of blood …